Jude Ngang

1.9k total citations
5 papers, 193 citations indexed

About

Jude Ngang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jude Ngang has authored 5 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in Jude Ngang's work include Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (2 papers). Jude Ngang is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (2 papers). Jude Ngang collaborates with scholars based in Australia, United States and United Kingdom. Jude Ngang's co-authors include Gerald S. Falchook, Ramaswamy Govindan, Erik Rasmussen, Marwan Fakih, Haby Henary, Jayesh Desai, David S. Hong, James Kuo, Phuong K. Morrow and Timothy Price and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Jude Ngang

5 papers receiving 192 citations

Peers

Jude Ngang
Jude Ngang
Citations per year, relative to Jude Ngang Jude Ngang (= 1×) peers Matteo Menotti

Countries citing papers authored by Jude Ngang

Since Specialization
Citations

This map shows the geographic impact of Jude Ngang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jude Ngang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jude Ngang more than expected).

Fields of papers citing papers by Jude Ngang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jude Ngang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jude Ngang. The network helps show where Jude Ngang may publish in the future.

Co-authorship network of co-authors of Jude Ngang

This figure shows the co-authorship network connecting the top 25 collaborators of Jude Ngang. A scholar is included among the top collaborators of Jude Ngang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jude Ngang. Jude Ngang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). OA01.06 Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1125–S1126. 3 indexed citations
2.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). OA02.02 Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC. Journal of Thoracic Oncology. 14(10). S208–S208. 30 indexed citations
3.
Govindan, Ramaswamy, Marwan Fakih, Gerald S. Falchook, et al.. (2019). P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1191–S1192. 3 indexed citations
4.
Fakih, Marwan, Bert H. O’Neil, Timothy Price, et al.. (2019). Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule KRASG12C inhibitor, in advanced solid tumors.. Journal of Clinical Oncology. 37(15_suppl). 3003–3003. 127 indexed citations
5.
Govindan, Ramaswamy, Marwan Fakih, Timothy Price, et al.. (2019). Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours. Annals of Oncology. 30. v163–v164. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026